Lysergic acid diethylamide (LSD) is a well-known hallucinogen that acts on serotonin receptors causing alterations in mood, thought processes, and sensory perception. The majority of the LSD manufactured in the United States has been consumed for recreational use, because it is classified as a Schedule I drug and has no approved medicinal use. Even though LSD is widely abused, it is not known to be highly addictive, and very few deaths are attributed to LSD alone. LSD has also been investigated by clinicians for the treatment of various neuropsychiatric disease states and for palliative purposes in end of life care. The goal of this educational program is to provide pharmacists and pharmacy technicians with information about LSD use, pharmacology, clinical presentation and management of toxicity, and developing uses in the treatment of psychiatric and neurologic disorders.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Course Content
Origins and History of LSD
Epidemiology
Availability
Properties of LSD
Pharmacology
Pharmacokinetics
Clinical Presentation of Intoxication
Physical Exam
Syndromes Associated with LSD
Patient Care
Complications of LSD
LSD Research Areas
Role of the Pharmacist
Section 3: Clinical Vignette
Clinical Vignette
Section 4: Conclusion
Summary
Course Contributors
References
Staff Writer: Laura Bell, BSN, RN, CCRNShana Jiang, PharmD, BCPS, received her Doctor of Pharmacy degree in 2014 from the Ernest Mario School of Pharmacy at Rutgers University and completed a pharmacy practice residency with Mount Sinai St. Luke's and Roosevelt Hospitals in New York, NY. She is now working as a telepharmacist for a major health system.
Disclosure: Shana Jiang, PharmD, BCPS has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Laura Bell, BSN, RN, CCRN is a SME writer for Relias with over 14 years of acute care experience in nursing. She began working in adult critical care at Wake Med Cary Hospital in 2011, obtained her CCRN certification in 2016, and served in the role of Rapid Response/Code Blue/Rounding RN for over 2 years. She continues to work as a staff nurse in the intensive care unit. Laura has a passion for education and excellence in nursing care. She has been involved in numerous special projects and educational activities to improve staff development, evidence-based clinical practice, and patient satisfaction. She continues to strive for excellence in education and clinical development as an acute care course writer. Disclosure: Laura Bell, BSN, RN, CCRN discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Relias LLC as a Salaried Employee All of the relationships listed for this individual have been mitigated.Relevant Non-Financial Relationship with No Entities Exists as a Contributor All of the relationships listed for this individual have been mitigated.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.